Perinatal origins of bronchopulmonary dysplasia-deciphering normal and impaired lung development cell by cell
- PMID: 37072570
- PMCID: PMC10113423
- DOI: 10.1186/s40348-023-00158-2
Perinatal origins of bronchopulmonary dysplasia-deciphering normal and impaired lung development cell by cell
Abstract
Bronchopulmonary dysplasia (BPD) is a multifactorial disease occurring as a consequence of premature birth, as well as antenatal and postnatal injury to the developing lung. BPD morbidity and severity depend on a complex interplay between prenatal and postnatal inflammation, mechanical ventilation, and oxygen therapy as well as associated prematurity-related complications. These initial hits result in ill-explored aberrant immune and reparative response, activation of pro-fibrotic and anti-angiogenic factors, which further perpetuate the injury. Histologically, the disease presents primarily by impaired lung development and an arrest in lung microvascular maturation. Consequently, BPD leads to respiratory complications beyond the neonatal period and may result in premature aging of the lung. While the numerous prenatal and postnatal stimuli contributing to BPD pathogenesis are relatively well known, the specific cell populations driving the injury, as well as underlying mechanisms are still not well understood. Recently, an effort to gain a more detailed insight into the cellular composition of the developing lung and its progenitor populations has unfold. Here, we provide an overview of the current knowledge regarding perinatal origin of BPD and discuss underlying mechanisms, as well as novel approaches to study the perturbed lung development.
Keywords: BPD; Lung development; Prematurity.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Perinatal Nutritional and Metabolic Pathways: Early Origins of Chronic Lung Diseases.Front Med (Lausanne). 2021 Jun 15;8:667315. doi: 10.3389/fmed.2021.667315. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34211985 Free PMC article. Review.
-
Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology.J Clin Med. 2023 Jun 22;12(13):4207. doi: 10.3390/jcm12134207. J Clin Med. 2023. PMID: 37445242 Free PMC article. Review.
-
Bronchopulmonary dysplasia.Nat Rev Dis Primers. 2019 Nov 14;5(1):78. doi: 10.1038/s41572-019-0127-7. Nat Rev Dis Primers. 2019. PMID: 31727986 Free PMC article. Review.
-
Endotypes of Prematurity and Phenotypes of Bronchopulmonary Dysplasia: Toward Personalized Neonatology.J Pers Med. 2022 Apr 26;12(5):687. doi: 10.3390/jpm12050687. J Pers Med. 2022. PMID: 35629108 Free PMC article. Review.
-
The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Front Med (Lausanne). 2017 May 22;4:61. doi: 10.3389/fmed.2017.00061. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28589122 Free PMC article. Review.
Cited by
-
Mesenchymal stromal/stem cells and bronchopulmonary dysplasia.Front Cell Dev Biol. 2023 Oct 30;11:1247339. doi: 10.3389/fcell.2023.1247339. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37965579 Free PMC article. Review.
-
Extracellular Vesicle ASC: A Novel Mediator for Lung-Brain Axis in Preterm Brain Injury.Am J Respir Cell Mol Biol. 2024 Oct;71(4):464-480. doi: 10.1165/rcmb.2023-0402OC. Am J Respir Cell Mol Biol. 2024. PMID: 38959416
-
Endothelial deletion of p53 generates transitional endothelial cells and improves lung development during neonatal hyperoxia.bioRxiv [Preprint]. 2024 May 8:2024.05.07.593014. doi: 10.1101/2024.05.07.593014. bioRxiv. 2024. PMID: 38766251 Free PMC article. Preprint.
References
Publication types
LinkOut - more resources
Full Text Sources